Persistent efficacy of tumor necrosis factor alpha blockage therapy in SAPHO syndrome: comment on the article by Wagner et al

Arthritis Rheum. 2003 May;48(5):1467; author reply 1467-8. doi: 10.1002/art.10937.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Acquired Hyperostosis Syndrome / drug therapy*
  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Humans
  • Infliximab
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Receptors, Tumor Necrosis Factor / antagonists & inhibitors*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Receptors, Tumor Necrosis Factor
  • Infliximab